Massachusetts General Hospital Epilepsy Service - WACC — Boston, Massachusetts

Massachusetts General Hospital Epilepsy Service - WACC is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Epilepsy Service - WACC has participated in 1 clinical trials.

Therapeutic areas: Epilepsy With Simple or Complex Partial Onset Seizures.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Epilepsy Service - WACC?

Massachusetts General Hospital Epilepsy Service - WACC has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Epilepsy Service - WACC conducted?

Massachusetts General Hospital Epilepsy Service - WACC has 1 clinical trials on record. Their work covers Epilepsy With Simple or Complex Partial Onset Seizures.

Is Massachusetts General Hospital Epilepsy Service - WACC accredited by Crixeo Health?

Massachusetts General Hospital Epilepsy Service - WACC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Epilepsy Service - WACC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.